Vocal cord dysfunction (VCD) in hospitalised exacerbations of asthma and chronic obstructive pulmonary disease (COPD).

L. Ruane (Melbourne, Australia), C. Daley (Melbourne, Australia), D. D'Souza (Melbourne, Australia), P. Leong (Melbourne, Australia), K. Low (Melbourne, Australia), K. Lau (Melbourne, Australia), K. Hamza (Melbourne, Australia), M. Macdonald (Melbourne, Australia), M. Baxter (Melbourne, Australia), P. Bardin (Melbourne, Australia)

Source: International Congress 2019 – Person-centred approaches to COPD and asthma care
Session: Person-centred approaches to COPD and asthma care
Session type: Oral Presentation
Number: 272
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Ruane (Melbourne, Australia), C. Daley (Melbourne, Australia), D. D'Souza (Melbourne, Australia), P. Leong (Melbourne, Australia), K. Low (Melbourne, Australia), K. Lau (Melbourne, Australia), K. Hamza (Melbourne, Australia), M. Macdonald (Melbourne, Australia), M. Baxter (Melbourne, Australia), P. Bardin (Melbourne, Australia). Vocal cord dysfunction (VCD) in hospitalised exacerbations of asthma and chronic obstructive pulmonary disease (COPD).. 272

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013


Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection?
Source: Eur Respir J 2001; 18: Suppl. 33, 172s
Year: 2001

Breathlessness during exacerbation of chronic obstructive pulmonary disease (ECOPD) and recovery
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019

Non-invasive ventilation and endothelial function in acute exacerbations of chronic obstructive pulmonary disease (COPD) patients
Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration
Year: 2019

Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005

Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


Effects of pulmonary rehabilitation on exacerbation number and severity in people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001

The relationship between fibroblasts and airway structure in patients with asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 148s
Year: 2001

Calorie-intake in patients hospitalized for an acute COPD exacerbation
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007



Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012


Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB)
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006

Prognosis after non-invasive ventiltation (NIV) for chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011

Large airways remodeling in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2008 - Pathophysiology of respiratory diseases
Year: 2008


Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008